SO
AMRX icon

STRS Ohio’s Amneal Pharmaceuticals AMRX Stock Holding History

STRS Ohio’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,600
Closed -$132K – 2165
2026
Q1 		$132K Buy
10,600
+6,500
+159% +$87.3K ﹤0.01% 1672
2025
Q4 		$51.7K Buy
+4,100
New +$46.9K ﹤0.01% 1968
2024
Q2 		– Sell
-108,500
Closed -$657K – 1957
2024
Q1 		$657K Sell
108,500
-19,000
-15% -$107K ﹤0.01% 1085
2023
Q4 		$773K Sell
127,500
-21,300
-14% -$94.9K ﹤0.01% 1006
2023
Q3 		$627K Sell
148,800
-44,400
-23% -$166K ﹤0.01% 1102
2023
Q2 		$598K Sell
193,200
-30,000
-13% -$63.9K ﹤0.01% 1176
2023
Q1 		$310K Hold
223,200
– – ﹤0.01% 1496
2022
Q4 		$444K Sell
223,200
-31,500
-12% -$70.6K ﹤0.01% 1371
2022
Q3 		$514K Buy
254,700
+60,300
+31% +$169K ﹤0.01% 1320
2022
Q2 		$618K Buy
194,400
+15,500
+9% +$56.1K ﹤0.01% 1233
2022
Q1 		$746K Sell
178,900
-12,900
-7% -$57.1K ﹤0.01% 1229
2021
Q4 		$918K Buy
191,800
+32,300
+20% +$161K ﹤0.01% 1170
2021
Q3 		$851K Buy
159,500
+3,600
+2% +$18.1K ﹤0.01% 1209
2021
Q2 		$798K Buy
155,900
+26,600
+21% +$151K ﹤0.01% 1338
2021
Q1 		$870K Sell
129,300
-24,100
-16% -$134K ﹤0.01% 1253
2020
Q4 		$701K Buy
153,400
+9,300
+6% +$41.2K ﹤0.01% 1275
2020
Q3 		$559K Buy
144,100
+28,600
+25% +$122K ﹤0.01% 1258
2020
Q2 		$549K Sell
115,500
-21,000
-15% -$86.5K ﹤0.01% 1240
2020
Q1 		$475K Hold
136,500
– – ﹤0.01% 1173
2019
Q4 		$657K Sell
136,500
-46,900
-26% -$163K ﹤0.01% 1238
2019
Q3 		$531K Buy
183,400
+158,200
+628% +$552K ﹤0.01% 1241
2019
Q2 		$180K Buy
25,200
+1,800
+8% +$18.4K ﹤0.01% 1726
2019
Q1 		$331K Hold
23,400
– – ﹤0.01% 1501
2018
Q4 		$316K Hold
23,400
– – ﹤0.01% 1487
2018
Q3 		$519K Sell
23,400
-2,000
-8% -$42.1K ﹤0.01% 1365
2018
Q2 		$416K Buy
+25,400
New +$446K ﹤0.01% 1457

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

STRS Ohio's AMRX Position: Q2 2026 in Review

STRS Ohio sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 10,600 shares — an estimated $132K sold.

STRS Ohio first reported a position in AMRX in Q2 2018 and held it in 26 quarters. The position peaked at $918K in Q4 2021. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • STRS Ohio reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 10,600 Amneal Pharmaceuticals shares in Q2 2026, an estimated $132K.
  • STRS Ohio first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 26 quarters.
  • STRS Ohio's Amneal Pharmaceuticals position peaked at $918K in Q4 2021.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.